Cargando…

Emerging Role of Metabolomics in Ovarian Cancer Diagnosis

Ovarian cancer is considered a silent killer due to the lack of clear symptoms and efficient diagnostic tools that often lead to late diagnoses. Over recent years, the impelling need for proficient biomarkers has led researchers to consider metabolomics, an emerging omics science that deals with ana...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saorin, Asia, Di Gregorio, Emanuela, Miolo, Gianmaria, Steffan, Agostino, Corona, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603269/ https://www.ncbi.nlm.nih.gov/pubmed/33086611 http://dx.doi.org/10.3390/metabo10100419

Ejemplares similares

From Metabolism to Genetics and Vice Versa: The Rising Role of Oncometabolites in Cancer Development and Therapy
por: Di Gregorio, Emanuela, et al.
Publicado: (2021)

Integration of Serum Metabolomics into Clinical Assessment to Improve Outcome Prediction of Metastatic Soft Tissue Sarcoma Patients Treated with Trabectedin
por: Miolo, Gianmaria, et al.
Publicado: (2020)

Radical Hemithoracic Radiotherapy Induces Systemic Metabolomics Changes That Are Associated with the Clinical Outcome of Malignant Pleural Mesothelioma Patients
por: Di Gregorio, Emanuela, et al.
Publicado: (2021)

The Riddle of Cetuximab-Related Skin Toxicity: (1)H-NMR Sebum Analysis Revealed Dynamic Lipid Alterations Associated with Skin Toxicity Development in Metastatic Colorectal Cancer Patients
por: Saorin, Asia, et al.
Publicado: (2022)

(1)H-NMR Plasma Lipoproteins Profile Analysis Reveals Lipid Metabolism Alterations in HER2-Positive Breast Cancer Patients
por: Corona, Giuseppe, et al.
Publicado: (2021)

Effect of Estrogen Receptor Status on Circulatory Immune and Metabolomics Profiles of HER2-Positive Breast Cancer Patients Enrolled for Neoadjuvant Targeted Chemotherapy
por: Vignoli, Alessia, et al.
Publicado: (2020)

Pharmacometabolomics of trabectedin in metastatic soft tissue sarcoma patients
por: Corona, Giuseppe, et al.
Publicado: (2023)

Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients
por: Corona, Giuseppe, et al.
Publicado: (2018)

Novel metabolomics-biohumoral biomarkers model for predicting survival of metastatic soft-tissue sarcomas
por: Vignoli, Alessia, et al.
Publicado: (2023)

Metabolic Clues to Bile Acid Patterns and Prolonged Survival in Patients with Metastatic Soft-Tissue Sarcoma Treated with Trabectedin
por: Miolo, Gianmaria, et al.
Publicado: (2023)

Carcinogenesis and Metastasis in Liver: Cell Physiological Basis
por: Rossetto, Anna, et al.
Publicado: (2019)

Overview of Epstein–Barr-Virus-Associated Gastric Cancer Correlated with Prognostic Classification and Development of Therapeutic Options
por: Re, Valli De, et al.
Publicado: (2020)

Quantitative Proteomic Approach Targeted to Fibrinogen β Chain in Tissue Gastric Carcinoma
por: Repetto, Ombretta, et al.
Publicado: (2018)

KIR-HLA Functional Repertoire Influences Trastuzumab Efficiency in Patients With HER2-Positive Breast Cancer
por: Muraro, Elena, et al.
Publicado: (2022)

Beyond MicroRNAs: Emerging Role of Other Non-Coding RNAs in HPV-Driven Cancers
por: Casarotto, Mariateresa, et al.
Publicado: (2020)

Epstein-Barr virus BART microRNAs in EBV- associated Hodgkin lymphoma and gastric cancer
por: De Re, Valli, et al.
Publicado: (2020)

Identification of a De Novo Xq26.2 Microduplication Encompassing FIRRE Gene in a Child with Intellectual Disability
por: Miolo, Gianmaria, et al.
Publicado: (2020)

Pharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer
por: Miolo, Gianmaria, et al.
Publicado: (2016)

Current Trends in Mucosal Melanomas: An Overview
por: Santeufemia, Davide Adriano, et al.
Publicado: (2023)

Emerging role of microRNAs in diagnosis and treatment of various diseases including ovarian cancer
por: Shah, Parag P, et al.
Publicado: (2009)

The Diagnosis of “Pervasive Developmental Disorder Not Otherwise Specified”: A Systematic Literature Review
por: Carbone, Agostino, et al.
Publicado: (2023)

Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype
por: Caggiari, Laura, et al.
Publicado: (2017)

The emerging roles of circular RNAs in ovarian cancer
por: Yang, Xuejing, et al.
Publicado: (2020)

Biomarkers in Prostate Cancer Diagnosis: From Current Knowledge to the Role of Metabolomics and Exosomes
por: Salciccia, Stefano, et al.
Publicado: (2021)

Emerging role of circular RNAs in the pathogenesis of ovarian cancer
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2022)

The Emerging Role of Chromatin Remodeling Complexes in Ovarian Cancer
por: Vaicekauskaitė, Ieva, et al.
Publicado: (2022)

Systemic Treatments for Advanced Small Bowel Adenocarcinoma: A Systematic Review
por: Di Nardo, Paola, et al.
Publicado: (2022)

Hereditary Cancer Syndromes: A Comprehensive Review with a Visual Tool
por: Garutti, Mattia, et al.
Publicado: (2023)

Polymorphism in Toll-Like Receptors and Helicobacter Pylori Motility in Autoimmune Atrophic Gastritis and Gastric Cancer
por: De Re, Valli, et al.
Publicado: (2019)

The Potential of Metabolomics in the Diagnosis of Thyroid Cancer
por: Coelho, Margarida, et al.
Publicado: (2020)

The emerging roles and therapeutic potential of exosomes in epithelial ovarian cancer
por: Li, Xiaoduan, et al.
Publicado: (2017)

HER2–CDH1 Interaction via Wnt/B-Catenin Is Associated with Patients’ Survival in HER2-Positive Metastatic Gastric Adenocarcinoma
por: De Re, Valli, et al.
Publicado: (2022)

Metabolomics: An Emerging Approach to Understand Pathogenesis and to Assess Diagnosis and Response to Treatment in Spondyloarthritis
por: Rizzo, Chiara, et al.
Publicado: (2022)

Role of Bruton’s Tyrosine Kinase in Stage III Colorectal Cancer
por: Basile, Debora, et al.
Publicado: (2019)

Emerging treatment options for recurrent ovarian cancer: the potential role of olaparib
por: Shaw, Heather M, et al.
Publicado: (2013)

Emerging Roles for Ion Channels in Ovarian Cancer: Pathomechanisms and Pharmacological Treatment
por: Altamura, Concetta, et al.
Publicado: (2021)

Emerging role of m6A methylation modification in ovarian cancer
por: Chang, Lin-Lin, et al.
Publicado: (2021)

The emerging roles of E3 ubiquitin ligases in ovarian cancer chemoresistance
por: Meng, Yang, et al.
Publicado: (2021)

The Emerging Role of PARP Inhibitors in the Treatment of Epithelial Ovarian Cancer
por: Gien, Lilian T., et al.
Publicado: (2010)

A new mutation of the CDH1 gene in a patient with an aggressive signet-ring cell carcinoma of the stomach
por: Caggiari, Laura, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_11clnqhi90p07vb0eokqov2urg